Although attaching an MITD to the immunogenic fragment of KRASG12V did not result in direct recognition of tumor cells by CD4+ T cells, studies have described a bias for endogenous peptides derived from membrane-bound proteins eluted from MHC-II, presumably due to membrane recycling (26, 32). The gene discussed is CD4; the disease is neoplasm.